Watch TXG. Know when insiders buy.
One email the day a filing lands. Free.
TXG
10x Genomics, Inc.
75.59
+4.13 +5.78%
USD · close Oct 21
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
36
FLAG · insiders 25, shorts 46
Insiders, 90 days
−$10.7M
net selling · 0 buys, 24 sells
Congress, 90 days
0 / 0
no disclosures naming it
Big money
1 / 15
tracked funds hold it
Calls on record
0
nobody we score has called it yet
MKT CAP $9.7BP/E —DIV YIELD —FCF YIELD 1.26%REV TTM $616.9M −4.3%NET INCOME −$75.1MNET CASH $314.3M52W 12.26 – 97.74SEC XBRL · TTM TO Invalid Date
Who holds it
| Fund | Type | Rank in portfolio | Value | Shares | As of |
|---|---|---|---|---|---|
| Duquesne Family Office (Stanley Druckenmiller) | Guru | #60 | $15.5M | 403K | 2026-06-30 |
13F filings cover US-listed holdings and arrive up to 45 days after quarter end, so positions may have changed since.
Stakes of 5% or more
ARK Investment Management LLC and 1 related5.2%
T. Rowe Price Associates, Inc.11.7%
A 13D means the holder crossed 5% with intent beyond passive ownership and had to state a purpose; a 13G is the passive version. Every new 13D on tracked companies.